Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy
Clinical Gastroenterology and Hepatology · 2024-08 · 22 (8) · 1668-1677
DOI: 10.1016/j.cgh.2024.02.027 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-08. Verfasst von Jean-Frédéric Colombel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic addre…. Hauptthemen laut MEDLINE: Crohn Disease, Heterocyclic Compounds, 3-Ring, Induction Chemotherapy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AbbVie.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: jean-frederic.colombel@mssm.edu.
- Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Mitaka-shi, Tokyo, Japan.
- Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany.
- Department of Gastroenterology, Dermatology, and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Gastroenterology, Fiona Stanley Hospital, Perth, Western Australia, Australia.
- Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
Förderung
- AbbVie
Zitieren
APA
Colombel, J. F., Hisamatsu, T., Atreya, R., Bresso, F., Thin, L., Panaccione, R., Parra, R. S., Ford, S., Remple, V. P., Lacerda, A. P., Anyanwu, S. I., Mallick, M., Garrison, A., & Regueiro, M. (2024). Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy. Clinical Gastroenterology and Hepatology, 22(8), 1668-1677. https://doi.org/10.1016/j.cgh.2024.02.027
Vancouver
Colombel JF, Hisamatsu T, Atreya R, Bresso F, Thin L, Panaccione R, et al. Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy. Clinical Gastroenterology and Hepatology. 2024;22(8):1668-1677. doi:10.1016/j.cgh.2024.02.027
BibTeX
@article{Colombel2024,
author = {Colombel, Jean-Frédéric and Hisamatsu, Tadakazu and Atreya, Raja and Bresso, Francesca and Thin, Lena and Panaccione, Remo and Parra, Rogério Serafim and Ford, Sharanya and Remple, Valencia P and Lacerda, Ana Paula and Anyanwu, Samuel I and Mallick, Madhuja and Garrison, Andrew and Regueiro, Miguel},
title = {Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
volume = {22},
number = {8},
pages = {1668--1677},
doi = {10.1016/j.cgh.2024.02.027}
}
EUVIMED